However, the same study has shown the relative increased expression of CDKN2A in histiocytes from HS cases, indicating that it is not necessarily through loss or the decreased expression of CDKN2A that this pathway is altered or suppressed in susceptible dogs. This evidence concerns the gene CDKN2A and histiocytic sarcoma.